|
Volumn 46, Issue 5, 2001, Pages 985-992
|
Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: Global and quantitative assessment
a a b a,c a,b |
Author keywords
Dyspepsia; Famotidine; H2 receptor antagonist; Recurrent abdominal pain
|
Indexed keywords
FAMOTIDINE;
HISTAMINE H2 RECEPTOR ANTAGONIST;
PLACEBO;
ABDOMINAL PAIN;
ARTICLE;
CHILD;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DYSPEPSIA;
GASTROINTESTINAL DISEASE;
HELICOBACTER PYLORI;
HUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT DISEASE;
SCORING SYSTEM;
SYMPTOMATOLOGY;
TREATMENT OUTCOME;
ABDOMINAL PAIN;
ADOLESCENT;
ANTI-ULCER AGENTS;
BREATH TESTS;
CHILD;
CHILD, PRESCHOOL;
DOUBLE-BLIND METHOD;
DYSPEPSIA;
FAMOTIDINE;
FEMALE;
HELICOBACTER INFECTIONS;
HISTAMINE H2 ANTAGONISTS;
HUMANS;
LACTOSE;
MALE;
PAIN MEASUREMENT;
TREATMENT OUTCOME;
|
EID: 0035035953
PISSN: 01632116
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1010793408132 Document Type: Article |
Times cited : (89)
|
References (18)
|